Matrix metalloproteinase-13 and membrane type-1 matrix metalloproteinase in peritoneal fluid of women with endometriosis
article
OA: closed
CC0
⤵ 28 in-corpus citations
AI-generated summary
This study found significantly lower concentrations of active MMP-13 and MT1-MMP/MMP-14 in the peritoneal fluid of women with endometriosis compared to controls.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: It is becoming more and more evident that different types of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are involved in the pathogenesis of endometriosis. The aim of the present study was to measure levels of the active forms of MMP-13 and membrane type-1 matrix metalloproteinase (MT1-MMP)/MMP-14 as well as TIMP-2 in the peritoneal fluid of women with endometriosis. STUDY DESIGN: We determined the levels of the active forms MMP-13 and MT1-MMP/MMP-14 as well as TIMP-2 in the peritoneal fluid of 20 women with endometriosis and 18 controls by different types of enzyme-linked immunosorbent assay. RESULTS: We found that the concentrations (mean +/- standard deviation) of total active MMP-13 and endogenous active MT1-MMP/MMP-14 in the peritoneal fluid of patients with endometriosis were 1.69 +/- 0.67 and 3.12 +/- 1.07 ng/ml, respectively. In control women the corresponding values were 3.02 +/- 0.43 and 4.45 +/- 1.03 ng/ml. The differences were statistically significant (p < 0.0001 and p < 0.0004 for MMP-13 and MMP-14, respectively). Levels of TIMP-2 did not differ significantly. CONCLUSIONS: Decreased concentrations of active MMP-13 and MT1-MMP/MMP-14 may imply that the proteolytic activity of the peritoneal milieu of women with endometriosis is disturbed, which may have implications in the pathogenesis of the disease.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (5)
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- W1775749144 via openalex
- W1971908494 via openalex
- W2025261380 via openalex
- W2111275713 via openalex
Cited by (28)
- Mesothelin as a diagnostic biomarker in endometriosis: A cross-sectional study 2025
- Unveiling the fibrotic puzzle of endometriosis: An overlooked concern calling for prompt action 2024
- Unveiling the fibrotic puzzle of endometriosis: An overlooked concern calling for prompt action 2024
- Is the leptin/BMI ratio a reliable biomarker for endometriosis? 2024
- The SPRi determination of cathepsin L and S in plasma and peritoneal fluid of women with endometriosis 2024
- Autoantibody screening of plasma and peritoneal fluid of patients with endometriosis 2023
- Analysis of Membrane Type-1 Matrix Metalloproteinase (MT1-MMP, MMP14) in Eutopic and Ectopic Endometrium and in Serum and Endocervical Mucus of Endometriosis 2023
- Evaluation of Proteasome and Immunoproteasome Levels in Plasma and Peritoneal Fluid in Patients with Endometriosis 2023
- Investigation of the Changes in Concentrations of Vitamin D-Binding Protein and Lactoferin in Plasma and Peritoneal Fluid of Patients with Endometriosis 2023
- The Influence of Lactoferrin in Plasma and Peritoneal Fluid on Iron Metabolism in Women with Endometriosis 2023
- Plasma and Peritoneal Poly (ADP-Ribose) Polymerase Levels in Patients with Endometriosis 2022
- The Role of Cadherin 12 (CDH12) in the Peritoneal Fluid among Patients with Endometriosis and Endometriosis-Related Infertility 2022
- Roles of microRNAs in Regulating Apoptosis in the Pathogenesis of Endometriosis 2022
- The Role of Matrix Metalloproteinases in Endometriosis: A Potential Target 2021
- Malignant Transformation and Associated Biomarkers of Ovarian Endometriosis: A Narrative Review 2020
- Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis 2018
- The bimodal role of matrix metalloproteinases and their inhibitors in etiology and pathogenesis of endometriosis (Review) 2018
- Profiling of Selected MicroRNAs in Proliferative Eutopic Endometrium of Women with Ovarian Endometriosis 2015
- Profiling of selected angiogenesis-related genes in proliferative eutopic endometrium of women with endometriosis 2013
- Determination of cathepsins B, D and G concentration in eutopic proliferative endometrium of women with endometriosis by the surface plasmon resonance imaging (SPRI) technique 2013
- Inflammation and ovarian cancer – current views 2013
- Chronic pelvic pain in menopausal women 2012
- The Local Immune Mechanisms Involved in the Formation of Endometriotic Lesions 2012
- Przewlek³y ból miednicy u kobiet w wieku menopauzalnym 2012
- Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases 2010
- Endometrial paradigms 2008
- Investigational drugs for endometriosis 2006
- Profiling of peritoneal fluid of women with endometriosis by chemokine protein array. 2006
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:15:35.797702+00:00
License: CC0
· commercial use OK